Outset Medical Inc. Common Stock
OMUnited States
5 filed reports · 228 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 810 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 689 | Dec 2025 |
Financial data
228 concepts · 1,499 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial224 concepts · 1,418 facts · Dec 2022 to Jun 2026
- Stockholders equity (US GAAP)16 · Dec 2022 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations15 · Dec 2022 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax13 · Dec 2023 to Jun 2026
- Restricted cash13 · Dec 2023 to Jun 2026
- Restricted cash and cash equivalents13 · Dec 2023 to Jun 2026
- Restricted cash equivalents13 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Gains losses on extinguishment of debt12 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Interest expense (US GAAP)12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
- Operating expenses (US GAAP)12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Research and development expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Selling and marketing expense (US GAAP)12 · Dec 2023 to Jun 2026
- Accretion amortization of discounts and premiums investments11 · Dec 2023 to Jun 2026
- Accrued warranty liability11 · Dec 2023 to Jun 2026
Product3 concepts · 80 facts · Dec 2023 to Jun 2026
- Revenue48 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)24 · Dec 2023 to Jun 2026
- Allocated share based compensation expense8 · Jun 2025 to Jun 2026
Geography1 concepts · 1 facts · Dec 2025
- Income taxes paid1 · Dec 2025
Segments
81 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service8 members · 80 facts
- Product24 · Dec 2023 to Jun 2026
- Service And Other Revenue24 · Dec 2023 to Jun 2026
- Consoles Product12 · Dec 2023 to Jun 2026
- Consumables Product12 · Dec 2023 to Jun 2026
- Cost Of Revenue2 · Jun 2025 to Jun 2026
- General And Administrative2 · Jun 2025 to Jun 2026
- Research And Development2 · Jun 2025 to Jun 2026
- Sales And Marketing2 · Jun 2025 to Jun 2026
Statement geographical1 member · 1 facts
- MX1 · Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
- FY2026 Q1May 7, 2026
- FY2025 Q4Feb 11, 2026
- FY2025 Q3Nov 10, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.